Krystal Biotech buy Bank of America Co.
Start price
14.07.26
/
50%
€297.90
Target price
14.07.27
€347.61
Performance (%)
-3.63%
Price
14.08.26
€287.10
Summary
This prediction is currently active. With a performance of -3.63%, the BUY prediction for Krystal Biotech by Bank_of_America_Co_ is down slightly. This prediction currently runs until 14.07.27. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Krystal Biotech | 1.736% | 1.736% |
| iShares Core DAX® | 0,44 % | 5,64 % |
| iShares Nasdaq 100 | 1,06 % | 0,28 % |
| iShares Nikkei 225® | 1,77 % | 0,41 % |
| iShares S&P 500 | 0,37 % | 1,92 % |
Comments by Bank_of_America_Co_ for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech (KRYS) had its price target raised by Bank of America Corporation from $364.00 to $396.00. They now have a "buy" rating on the stock.
Ratings data for KRYS provided by MarketBeat
Stopped prediction by Bank_of_America_Co_ for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€246.10
22.01.26
22.01.26
€272.02
22.01.27
22.01.27
16.66%
14.08.26
14.08.26
Krystal Biotech
Start price
Target price
Perf. (%)
€159.10
17.10.25
17.10.25
€217.90
17.10.26
17.10.26
80.45%
14.08.26
14.08.26
Krystal Biotech
Start price
Target price
Perf. (%)
€129.30
22.07.25
22.07.25
€164.24
22.07.26
22.07.26
125.52%
23.07.26
23.07.26